Fibroblast growth factor in extremities

研究成果: Chapter in Book/Report/Conference proceedingChapter

1 被引用数 (Scopus)

抄録

Fibroblast growth factor (FGF) is recognized as one of the major angiogenic factors. Among the FGF family members, FGF-1 (acidic fibroblast growth factor, aFGF) and FGF-2 (basic fibroblast growth factor, bFGF) have been extensively studied at both preclinical and clinical stages for applications in therapeutic angiogenesis. In vivo studies have reported various synergistic effects of FGF-2, and gene therapy has achieved promising results in early preclinical studies. However, few clinical trials have been conducted. In this chapter, we provide an overview and future perspectives of the progression of research into angiogenic gene therapy with FGF for peripheral artery disease. The focus of a new gene transfer vector based on a non-transmissible recombinant Sendai virus that expresses the human FGF-2 gene is also introduced as a frontier of therapeutic angiogenesis in this field.

本文言語英語
ホスト出版物のタイトルTherapeutic Angiogenesis
出版社Springer Singapore
ページ145-158
ページ数14
ISBN(電子版)9789811027444
ISBN(印刷版)9789811027437
DOI
出版ステータス出版済み - 7 11 2017

All Science Journal Classification (ASJC) codes

  • 工学(全般)
  • コンピュータ サイエンス(全般)

フィンガープリント

「Fibroblast growth factor in extremities」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル